Central nervous system toxicity after botulinum neurotoxin injection

Area of Science:

• Neurology
• Toxicology

Background:

• Botulinum neurotoxin (BoNT) formulations offer clinical benefits for various conditions.
• Adverse events associated with BoNT treatments are increasingly reported to regulatory agencies.

Observation:

• A 62-year-old woman with Parkinson's disease received BoNT injections for hand spasticity.
• The patient developed severe generalized dystonia shortly after the injections.

Findings:

• This case report details a severe adverse event following therapeutic BoNT administration.
• Generalized dystonia emerged as a complication in a patient with pre-existing neurological condition.

Implications:

• Highlights the need for careful patient selection and monitoring during BoNT therapy.
• Suggests potential risks of BoNT-induced dystonia, particularly in vulnerable patient populations.
• Underscores the importance of reporting and analyzing adverse events to enhance treatment safety.